Compounds > quinaprilat
Page last updated: 2024-09-02

quinaprilat and angiotensin i

quinaprilat has been researched along with angiotensin i in 8 studies

Compound Research Comparison

Studies
(quinaprilat)		Trials
(quinaprilat)		Recent Studies (post-2010)
(quinaprilat)		Studies
(angiotensin i)		Trials
(angiotensin i)		Recent Studies (post-2010) (angiotensin i)
922344,2181251,253

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's5 (62.50)29.6817
2010's0 (0.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Bara, AT; Busse, R; Hecker, M; Pörsti, I1
Bumpus, FM; Husain, A; Kinoshita, A; Urata, H1
Danser, AH; de Vries, R; Saxena, PR; Tom, B1
Danser, AH; de Vries, R; Saxena, PR; Schalekamp, MA; Schuijt, MP1
Batenburg, WW; Danser, AH; de Bruijn, RJ; de Vries, R; Dive, V; Georgiadis, D; Tom, B; van Esch, JH; van Gool, JM; Yiotakis, A1
Faramarzi, S; Grimm, D; Grosse, J; Habighorst, B; Infanger, M; J Danser, AH; Kossmehl, P; Kreutz, R; Kurth, E; Paul, M; Shakibaei, M; Wehland, M1
de Bruin, RJ; Deinum, J; Dive, V; Hectors, M; Jan Danser, AH; Montgomery, HE; Payne, JR; van Esch, JH; van Gool, JM1
Balachandran, K; Ozkizilcik, A; Patel, S; Sysavanh, F; Tandon, I1

Other Studies

8 other study(ies) available for quinaprilat and angiotensin i

ArticleYear
Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor.
    British journal of pharmacology, 1994, Volume: 111, Issue:3

    Topics: Amino Acid Sequence; Angiotensin I; Angiotensin II; Animals; Arginine; Bradykinin; Coronary Vessels; Endothelium, Vascular; In Vitro Techniques; Isoquinolines; Molecular Sequence Data; Muscle Relaxation; Nitric Oxide; Nitroarginine; Peptide Fragments; Receptors, Angiotensin; Swine; Tetrahydroisoquinolines; Vasodilator Agents

1994
Measurement of angiotensin I converting enzyme inhibition in the heart.
    Circulation research, 1993, Volume: 73, Issue:1

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Captopril; Cricetinae; Dipeptides; Enalaprilat; Humans; Isoquinolines; Lisinopril; Male; Mesocricetus; Papillary Muscles; Tetrahydroisoquinolines

1993
Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
    Hypertension (Dallas, Tex. : 1979), 2001, Volume: 38, Issue:1

    Topics: Adolescent; Adult; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; Coronary Vessels; Drug Synergism; Female; Humans; In Vitro Techniques; Isoquinolines; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Structure, Tertiary; Receptor, Bradykinin B2; Receptors, Bradykinin; Swine; Tetrahydroisoquinolines; Vasodilation

2001
Vasoconstriction is determined by interstitial rather than circulating angiotensin II.
    British journal of pharmacology, 2002, Volume: 135, Issue:1

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Carotid Arteries; Dose-Response Relationship, Drug; Femoral Artery; Imidazoles; In Vitro Techniques; Irbesartan; Isoquinolines; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Swine; Tetrahydroisoquinolines; Tetrazoles; Vasoconstriction; Vasoconstrictor Agents

2002
Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction.
    Hypertension (Dallas, Tex. : 1979), 2005, Volume: 45, Issue:1

    Topics: Adolescent; Adult; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; Coronary Vessels; Dose-Response Relationship, Drug; Female; Femoral Artery; Humans; Male; Microcirculation; Middle Aged; Oligopeptides; Organ Specificity; Peptidyl-Dipeptidase A; Phosphinic Acids; Protein Structure, Tertiary; Solubility; Structure-Activity Relationship; Sus scrofa; Tetrahydroisoquinolines; Vasoconstriction

2005
Mechanisms of apoptosis after ischemia and reperfusion: role of the renin-angiotensin system.
    Apoptosis : an international journal on programmed cell death, 2006, Volume: 11, Issue:3

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Shape; fas Receptor; Female; Heart; Myocardial Infarction; Myocardium; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Random Allocation; Renin-Angiotensin System; Reperfusion Injury; Swine; Tetrahydroisoquinolines; Tumor Suppressor Protein p53

2006
Different contributions of the angiotensin-converting enzyme C-domain and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype.
    Journal of hypertension, 2008, Volume: 26, Issue:4

    Topics: Adult; Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Vessels; Enzyme Activation; Female; Genotype; Humans; In Vitro Techniques; Male; Middle Aged; Oligopeptides; Peptidyl-Dipeptidase A; Phosphinic Acids; Point Mutation; Protein Structure, Tertiary; Sus scrofa; Tetrahydroisoquinolines; Vasoconstrictor Agents; Vasodilator Agents

2008
Local Renin-Angiotensin System Signaling Mediates Cellular Function of Aortic Valves.
    Annals of biomedical engineering, 2021, Volume: 49, Issue:12

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve; Cells, Cultured; Fluorescent Antibody Technique; Losartan; Myofibroblasts; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Swine; Tetrahydroisoquinolines

2021